Air India and IndiGo have already suspended Kamra from flying until further notice and six months, respectively.
As for Bharat Biotech, the Subject Expert Committee (SEC) on COVID-19 of the CDSCO asked the firm to expedite volunteer recruitment for the ongoing clinical trial and said it may conduct interim efficacy analysis for further consideration of restricted emergency use approval for its vaccine Covaxin, they stated.
Another woman from Malda district said that her son was killed in the accident.
Several opposition MPs on Wednesday demanded an explanation from Home Minister Amit Shah after two visitors jumped into the Lok Sabha chamber from the visitors' gallery and opened canisters that emitted coloured smoke, triggering panic among the members.
With the maximum dose gap of four months for Covishield, a large part of the population would not even be eligible for the second dose by the end of this year, report Ruchika Chitravanshi and Ishaan Gera.
More than 300 verified mobile phone numbers, including of two serving ministers, over 40 journalists, three opposition leaders and one sitting judge besides scores of business persons and activists in India could have been targeted for hacking through an Israeli spyware sold only to government agencies, an international media consortium reported on Sunday.
A coordination committee shall monitor the start up clearances to manage and prioritise the movement of flights during fog.
The panel also recommended giving approval to Bharat Biotech for carrying out a study on interchangeability of its Covaxin and the under-trial adenoviral intranasal vaccine candidate BBV154, but asked the Hyderabad-based firm to remove the word "interchangeability" from the study title and submit a revised protocol for approval.
LHB coaches are safer. Two high-level railway safety commissions came down heavily on ICF coaches, recommending their replacement by LHB, says Bibek Debroy.
The Pune-based firm had submitted interim safety and immunogenicity data of phase 2/3 bridging clinical trial conducted in the country as well as interim clinical trial data of safety and efficacy from phase3 clinical trials conducted in the UK and the US along with its application.
Amid concerns over dangerous side-effects of the Oxford's COVID-19 vaccine, India is evaluating all serious adverse events post-vaccination to determine the causality aspects of Covishield and Covaxin, an expert associated with the process said on Saturday.
The inquiry into the March 9 incident was done by Assistant Chief of Air Staff Operations (Offensive) Air Vice Marshal R K Sinha where during routine maintenance and inspection, a BrahMos missile got fired accidentally and landed up in the Mian Channu area of Pakistan.
The government on Friday tweaked IT rules to pave the way for setting up of grievance appellate panels, which will settle issues that users may have against the way social media platforms initially addressed their complaints regarding content and other matters.
Covaxin was found to have 78 per cent efficacy against COVID-19 of any severity, 14 or more days after the second dose, and is extremely suitable for low- and middle-income countries due to easy storage requirements, said the global health body.
Bharat Biotech recruited 13,000 participants for the Phase-3 clinical trial of Covaxin. This is one of the largest efficacy trials held in the country.
The UK's medicines regulator on Friday approved the Pfizer/BioNTech coronavirus vaccine for 12 to 15 year olds.
Vaccine development is a long process to ensure safety and efficacy through different stages and involves regulatory supervision every step of the way. Ruchika Chitravanshi takes you through this carefully drawn journey of vaccine development.
Earlier this year, Toyota Motor Corp was fined $1.2 billion for concealing problems related to sudden acceleration of some of its vehicles.
Once the UK drug regulator gives its approval to the Oxford vaccine, the expert committee on COVID-19 at the Central Drugs Standard Control Organisation (CDSCO) will hold its meeting and thoroughly review the safety and immunogenicity data from the clinical evaluations conducted abroad and in India before granting any emergency authorisation for the vaccine here, official sources said.
'You can still hear gunshots, and this time even children know they are not normal.'
'I am of the opinion the attention received by Phillip after being struck had no role whatsoever on his subsequent demise, due to the nature and severity of his injury'
Besides opposing the suspension of three medicines, the sector has also questioned the process adopted by the government.
The institute expects to complete both, phase-2 and 3 trials in India by the end of this year.
Pakistan is bracing for another day of violence that broke out in many cities after the arrest of former prime minister Imran Khan for alleged corruption with the leaders of his party announcing a countrywide strike on Wednesday to protest against the fascist government.
The administration started preparing for the demolition of two precariously standing hotels in subsidence-hit Joshimath in Uttarakhand on Tuesday, but faced protests from their owners and locals on the issue of compensation, while more families were evacuated from the danger zone as the number of affected houses rose to over 700.
Japanese organisers have decided to ban spectators from venues of the Olympics
A technical advisory group of the World Health Organisation was on Tuesday reviewing data on Covaxin for the emergency use listing of India's indigenously-made vaccine and it could pronounce its decision within the next 24 hours or so, a spokesperson said.
'No approval was given to Sputnik V on Thursday. Some queries have been asked on safety, efficacy, and logistics, which the firm will have answers to at the next meeting'
The SIM card of the deceased is believed to have helped identify him.
President-elect Joe Biden's low-key inauguration on January 20 will include a Pass in Review on the East Front, a presidential escort to the White House, and a virtual parade across America following his official swearing in at the United States Capitol, the Presidential Inaugural Committee has announced.
He also held another meeting with a delegation of civil society organisations as part of his outreach and they expressed their commitment to peace and assured that they would work for restoring normalcy in Manipur.
According to sources, around 10 crore doses of the Sputnik V vaccine is likely to be imported for emergency use in the country in the next six to seven months.
The announcement comes a day after the Subject Expert Committee (SEC) on COVID-19 of the CDSCO recommended granting emergency use authorisation (EUA) to the COVID-19 vaccines Covovax and Corbevax with certain conditions.
Poland, which has long been critical of Lukashenko and harboured many activists from Belarus, has granted her and her husband humanitarian visas.
The global trials were halted after a study participant suffered a 'potentially unexplained illness, reports Sohini Das.
The technical advisory group will now meet on November 3 for a final assessment.
Covaxin is being developed by Bharat Biotech jointly with the Indian Council of Medical Research (ICMR)- National Institute of Virology (NIV). The Phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000 volunteers and it is the country's first and only Phase III efficacy study for a COVID-19 vaccine, a press release from the vaccine maker said on Saturday night.
Many families in the affected area are finding it hard to sever their emotional ties with their homes and move out.
Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology (DBT) said on Friday.
According to Davis Cup regulations, the Pakistan Tennis Federation now has five working days to choose and confirm their proposed venue.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances